Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Medtronic
Cerilliant
Citi
Deloitte
McKesson
Cantor Fitzgerald
Harvard Business School
Queensland Health

Generated: April 23, 2018

DrugPatentWatch Database Preview

CELEXA Drug Profile

« Back to Dashboard

Drug patent expirations by year for CELEXA
Pharmacology for CELEXA
Medical Subject Heading (MeSH) Categories for CELEXA
Synonyms for CELEXA
(S)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide
[3H]-Citalopram
[3H]Citalopram
[3H]Cytalopram
[3H]Escitalopram
[3H]Lexapro
1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide
1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrobromide
1-(3-(dimethylamino)propyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile monohydrobromide
1-(3-(Dimethylamino)propyl)-1,-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrobromide
1-(3-Dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile
1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
1-(3'-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
1-[3-(dimethylamino) propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzo[b]furancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile
1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile hydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carb onitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide
1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIZOHYDRO-5-ISOBENZOFURANCARBONITRILE HYDROBROMIDE SALT
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile hydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile hydrobromide
1-[3-(dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
4793-EP2275420A1
4793-EP2284166A1
4793-EP2298764A1
4793-EP2298765A1
4793-EP2305648A1
4CH-017662
5-Cyano-1-(4-fluorophenyl)-1-(3-dimethylaminopropyl)-1,3-dihydro-isobenzofuran
5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-
5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, monohydrobromide
5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,monohydrobromide
5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-
5-ISOBENZOFURANCARBONITRILE, 1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-, HYDROBROMIDE (1:1)
5-Isobenzofurancarbonitrile, 1,3-dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-
5-Isobenzofurancarbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-
59729-32-7
59729-33-8
65822P
729C327
729C338
A832439
AB00513896
AB00513896_12
AB00513896_13
AB00513896-09
AB00513896-11
AB0107058
AB1010898
AB10921
AC-1595
AC-8894
AC1L1EFH
AC1L2U9E
ACT02666
AE-641/00603021
AK-72795
AK326208
Akarin
Akarin (TN)
AKOS005145738
AKOS005711003
AN-14765
AN-5829
ANW-42935
Apertia
API0006328
ARK092
AX8121801
BBL029066
BC204213
BC207875
BCP9000537
BDBM25870
BG0143
Bio-0019
Bonitrile
Bonitrile HBr
BPBio1_000929
BR-72795
BRD-A47598013-004-02-0
BSPBio_000843
C 7861
C07572
C20H21FN2O
C20H21FN2O.HBr
CCG-101022
CCG-204353
CCG-213271
Celapram
Celapram (TN)
Celexa (TN)
Celius
Celius (TN)
CHEBI:77397
CHEMBL1200781
CHEMBL549
Ciazil
Ciazil (TN)
Cilift
Cilift (TN)
Cipram
Cipram (TN)
Cipramil
Cipramil (TN)
Ciprapine
Ciprapine (TN)
Citabax
Citabax (TN)
Citadur
Citadur (TN)
Citalec
Citalec (TN)
citalopram
Citalopram (hydrobromide)
Citalopram (USP/INN)
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram [USP:INN:BAN]
CITALOPRAM BROMOHYDRATE
Citalopram for system suitability, European Pharmacopoeia (EP) Reference Standard
Citalopram HBr
citalopram hydrobromide
Citalopram hydrobromide (USAN)
Citalopram hydrobromide [USAN:USP]
Citalopram hydrobromide [USAN]
Citalopram Hydrobromide 0.1 mg/ml in Methanol (as free base)
Citalopram Hydrobromide 1.0 mg/ml in Methanol (as free base)
Citalopram hydrobromide, >=98% (HPLC)
Citalopram hydrobromide, European Pharmacopoeia (EP) Reference Standard
Citalopram Hydrobromide, pharmaceutical secondary standard; traceable to USP, PhEur
Citalopram hydrobromide, United States Pharmacopeia (USP) Reference Standard
Citalopram-d4 oxalate
CITALOPRAM, HYDROBROMIDE SALT
Citalopramum
Citalopramum [INN-Latin]
Citaxin (TN)
Citol (TN)
Citopam
Citopam (TN)
Citox (TN)
Citrol (TN)
CPD000326936
CPD000465669
CS-4735
CTK8B3679
Cytalopram
D00822
D07704
D0Y5DO
Dalsan
Dalsan (TN)
DB00215
DTXSID40872344
DTXSID8022826
EINECS 261-890-6
EINECS 261-891-1
Elopram
EN300-304884
Escitalopram Impurity A
EU-0100258
FT-0600173
FT-0657967
GTPL4621
GTPL7547
HE062045
HE175796
HE358063
HMS2090O09
HMS2093A14
HMS3259B10
HSDB 7042
Humorup
HY-B1287
I01-0382
I06-0616
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
J10477
KB-217184
KS-00000FXR
KS-1043
L001223
Lopac0_000258
LP00258
LS-84327
LS-84329
Lu 10-171
Lu 10-171 HBr
Lu 10-171-B
Lu-10-171
LU-10-171 HYDROBROMIDE SALT
Lu-10-171B
LU-10171B
Lupram
MCULE-5882770916
MFCD02101306
MLS000028578
MLS000758293
MLS000860078
MLS001401376
MLS002222294
MLS006011858
MolPort-003-666-794
MolPort-003-940-770
MRF-0000302
NC00272
NC00711
NCGC00015267-04
NCGC00015267-05
NCGC00015267-07
NCGC00015267-09
NCGC00025160-02
NCGC00093717-01
NCGC00093717-02
NCGC00093717-03
NCGC00260943-01
Nitalapram
Nitalapram HBr
NITALAPRAM HYDROBROMIDE SALT
NSC-758684
NSC758684
Oropram
Perrigo citalopram
Pharmakon1600-01504172
Pramcit
Prepram HBr
Prestwick3_000692
Prisdal
Q-200865
Recital
Recital (TN)
recital hydrobromide
RP17855
s4749
SAM001246599
SAM001247086
SAM002589960
SBI-0050246.P002
SC-16253
SC-18021
SCHEMBL1118
SCHEMBL946
Sepram
Seropram
Seropram (TN)
SMR000326936
SMR000465669
ST069372
ST2403129
STL058639
Talam
Talam (TN)
Talohexal
Temperax
TL8003797
Tox21_500258
TR-020691
VA10838
Vodelax
W-105304
WIHMBLDNRMIGDW-UHFFFAOYSA-N
WSEQXVZVJXJVFP-UHFFFAOYSA-
WSEQXVZVJXJVFP-UHFFFAOYSA-N
Z1550648760
ZD-211
Zentius
Zentius (TN)
Zetalo
Zetalo (TN)

US Patents and Regulatory Information for CELEXA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs CELEXA citalopram hydrobromide SOLUTION;ORAL 021046-001 Dec 22, 1999 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc CELEXA citalopram hydrobromide TABLET;ORAL 020822-003 Jul 17, 1998 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc CELEXA citalopram hydrobromide TABLET;ORAL 020822-001 Apr 27, 2000 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc CELEXA citalopram hydrobromide TABLET;ORAL 020822-002 Jul 17, 1998 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
Medtronic
Accenture
McKinsey
US Army
Cipla
Chubb
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.